GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » Cash Flow for Dividends

BioGend Therapeutics Co (ROCO:6733) Cash Flow for Dividends : NT$0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioGend Therapeutics Co Cash Flow for Dividends?

BioGend Therapeutics Co's cash flow for dividends for the three months ended in Dec. 2024 was NT$0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

BioGend Therapeutics Co Cash Flow for Dividends Historical Data

The historical data trend for BioGend Therapeutics Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGend Therapeutics Co Cash Flow for Dividends Chart

BioGend Therapeutics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only - - - - -

BioGend Therapeutics Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BioGend Therapeutics Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGend Therapeutics Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of BioGend Therapeutics Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGend Therapeutics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » Cash Flow for Dividends
Comparable Companies
ROCO:7808 ROCO:1777 TPE:6885 TPE:6794 ROCO:6492 ROCO:06891 ROCO:6808 ROCO:6634 ROCO:6461 ROCO:6945 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Yuanqu Street, 4th Floor, Number 3-2, Nangang District, Taipei, TWN, 115
Website
https://www.biogend.com.tw
BioGend Therapeutics Co Ltd is a Taiwan-based company involved in the research and development of orthopedic medical equipment and related products and the sale of related products. It is involved in the research and development of innovative cartilage repair technology and products, adipose stem cell extraction technology, and others. Geographically, the company generates a majority of its revenue from Taiwan followed by China and other regions.

BioGend Therapeutics Co Headlines

No Headlines